Clinical applications of cytokinesPESCHEL, C; HUBER, C; AULITZKY, W. E et al.La Presse médicale (1983). 1994, Vol 23, Num 23, pp 1083-1091, issn 0755-4982Article

Cytokine therapy of neoplastic and inflammatory diseaseAULITZKY, W. E; HUBER, C; PESCHEL, C et al.International archives of allergy and immunology. 1993, Vol 101, Num 3, pp 221-226, issn 1018-2438Article

Biotherapy of chronic myelogenous leukemiaAULITZKY, W. E; PESCHEL, C; SCHNELLER, F et al.Annals of hematology (Print). 1995, Vol 70, Num 3, pp 113-120, issn 0939-5555Article

Fractionated administration of high-dose cyclophosphamide: influence on dose-dependent changes in pharmacokinetics and metabolismBUSSE, D; BUSCH, F. W; SCHWEIZER, E et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, Num 3, pp 263-268, issn 0344-5704Article

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer : Results of a phase II studySCHULER, M; BRUNTSCH, U; SPÄTH-SCHWALBE, E et al.European journal of cancer (1990). 1998, Vol 34, Num 5, pp 754-756, issn 0959-8049Article

Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy : Toxicity, pharmacokinetics, and biological effectsLORENZ, J; WILHELM, K; KESSLER, M et al.Clinical cancer research. 1996, Vol 2, Num 7, pp 1115-1122, issn 1078-0432Article

Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2ZISSEL, G; AULITZKY, W. E; LORENZ, J et al.Cancer immunology and immunotherapy. 1996, Vol 42, Num 2, pp 122-126, issn 0340-7004Article

Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia : results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemiaSCHÖNBOHN, H; SCHULER, M; KOLBE, K et al.Annals of hematology (Print). 1995, Vol 71, Num 4, pp 161-168, issn 0939-5555Article

Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantationTILG, H; NORDBERG, J; VOGEL, W et al.Transplantation. 1992, Vol 54, Num 1, pp 142-146, issn 0041-1337Article

Human monoclonal antibodies neutralizing cytomegalovirus (CMV) for prophylaxis of CMV disease : report of a phase I trial in bone marrow transplant recipientsAULITZKY, W. E; SCHULZ, T. F; DIERICH, M. P et al.The Journal of infectious diseases. 1991, Vol 163, Num 6, pp 1344-1347, issn 0022-1899, 4 p.Article

Acute effects of single doses of recombinant interferon-γ on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancerAULITZKY, W. E; AULITZKY, W; GASTL, G et al.Journal of interferon research. 1989, Vol 9, Num 4, pp 425-433, issn 0197-8357Article

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialSTÖLZEL, F; PFIRRMANN, M; SCHMITZ, N et al.Leukemia. 2011, Vol 25, Num 3, pp 420-428, issn 0887-6924, 9 p.Article

Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cellsFANTA, S; SONNENBERG, M; SKORTA, I et al.Oncogene (Basingstoke). 2008, Vol 27, Num 31, pp 4380-4384, issn 0950-9232, 5 p.Article

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma : Results of the international randomized phase III trial (MISTRAL)BETTICHER, D. C; MARTINELLI, G; COGLIATTI, S. B et al.Annals of oncology. 2006, Vol 17, Num 10, pp 1546-1552, issn 0923-7534, 7 p.Article

Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancerPORTIELJE, J. E. A; KRUIT, W. H. J; AULITZKY, W. E et al.Clinical cancer research. 1999, Vol 5, Num 12, pp 3983-3989, issn 1078-0432Article

Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivoAMAN, M. J; STOCKDREHER, K; THEWS, A et al.Annals of hematology (Print). 1996, Vol 73, Num 5, pp 231-238, issn 0939-5555Article

Low-dose γ-interferon therapy is ineffective in renal cell carcinoma patients with large tumour burdenAULITZKY, W. E; LERCHE, J; HUBER, C et al.European journal of cancer. Part A. 1994, Vol 30, Num 7, pp 940-945Article

Cachexia and tumour necrosis factor-α in cytomegalovirus infectionTILG, H; VOGEL, W; HEROLD, M et al.Journal of clinical pathology. 1991, Vol 44, Num 6, pp 519-520, issn 0021-9746Article

Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantationTILG, H; WOGEL, W; AULITZKY, W. E et al.Transplantation. 1990, Vol 49, Num 6, pp 1074-1080, issn 0041-1337, 7 p.Article

Recombinant interferon beta in chronic myelogenous leukemiaAULITZKY, W. E; DESPRES, D; RUDOLF, G et al.Seminars in hematology. 1993, Vol 30, Num 3, pp 14-16, issn 0037-1963, SUP3Conference Paper

Second malignancies after Ewing tumor treatment in 690 patients from a cooperative german/austrian/dutch studyPAULUSSEN, M; AHRENS, S; NIEMEYER, C et al.Annals of oncology. 2001, Vol 12, Num 11, pp 1619-1630, issn 0923-7534Article

Overexpression of mouse p140 subunit of replication factor C accelerates cellular proliferationJAHARUL HAQUE, S; VAN DER KUIP, H; ASEEM KUMAR et al.Cell growth and differentiation. 1996, Vol 7, Num 3, pp 319-326, issn 1044-9523Article

Cationic lipid mediated transfer of c-abl and bcr antisense oligonucleotides to immature normal myeloid cells : Uptake, biological effects and modulation of gene expressionALBRECHT, T; SCHWAB, R; PESCHEL, C et al.Annals of hematology (Print). 1996, Vol 72, Num 2, pp 73-79, issn 0939-5555Article

Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawalALBRECHT, T; SCHWAB, R; HENKES, M et al.British journal of haematology. 1996, Vol 95, Num 3, pp 501-507, issn 0007-1048Article

Induction of circulating IL-1 receptor antagonist by IFN treatmentTILG, H; MIER, J. W; VOGEL, W et al.The Journal of immunology (1950). 1993, Vol 150, Num 10, pp 4687-4692, issn 0022-1767Article